Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CRDL: Cardiol Therapeutics Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
CRDL
The Story
CRDL
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-146.4%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
4.39×
Cardiol Therapeutics Inc.
CRDL
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Cardiol Therapeutics Inc.
CRDL
NASDAQ
·
USD
·
Closed
$1.27
+4.96%
$1.27
+$0.06 (4.96%)
52W Range
47th
pctl
Volume
2.13×
avg
Mkt Cap
146.40M
USD
P/E
-4.5
TTM
Div Yield
–
ann
52W Range
47th
pctl
Volume
2.13×
avg
Market Cap
146.40M
USD
P/E Ratio
-4.5
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings